Sjeng Horbach Consultancy

About Sjeng Horbach Consultancy

Sjeng Horbach Consultancy specializes in providing consultancy services in the field of in pre-clinical toxicology, drug safety and drug development to small- and mid-sized companies and start-ups. Sjeng Horbach Consultancy can be your partner in designing a preclinical drug safety development programme tailor-made for the specific needs of your compound and clinical target. Although we focus on drug safety in the early part of drug development, from lead optimization to clinical phase I, we can also be your intermediary for obtaining support for your late stage development projects by bringing you in contact with experienced scientists in various fields of drug discovery and development.

Sjeng Horbach Consultancy was founded in January 2012 to provide support to small- and mid-sized companies and start-ups. The career of Sjeng Horbach has spanned over 35 years with CRO, university and pharmaceutical companies, most recently with Genmab in The Netherlands, where he was heading the Non-clinical Safety and Toxicology group. Sjeng Horbach has a broad experience in preclinical development of pharmaceuticals, both small molecules and biologicals. The projects he has been involved in cover a wide spectrum of therapeutic areas, such as CNS, oncology and fertility. Sjeng has a MSc degree in Biochemistry and Molecular Biology from the University of Leiden and a PhD from the University of Maastricht. He is (co-)author of over 50 papers in peer reviewed journals as well as (co-) author of over 25 review papers and book chapters.

Our services in preclinical drug development include: - design and implementation of a preclinical drug development plan - support in outsourcing preclinical studies and choice of CRO’s - monitor studies outsourced at a CRO - review of toxicological study reports provided by the CRO - getting you in contact with other specialists to answer questions outside our area of expertise - evaluation of preclinical dossiers

Keywords

• Drug Development
• Preclinical Toxicology

Address

• Headquarters

  Polderkade 15345 OssNoord-Brabant, Netherlands